tiprankstipranks
Trending News
More News >
Mettler-Toledo International (MTD)
NYSE:MTD

Mettler-Toledo (MTD) AI Stock Analysis

Compare
511 Followers

Top Page

MTD

Mettler-Toledo

(NYSE:MTD)

Select Model
Select Model
Select Model
Rating:71Outperform
Price Target:
$1,614.00
▲(17.53% Upside)
Mettler-Toledo scores a 71, driven primarily by strong technical momentum and resilient operational execution. The company continues to generate robust cash flow and manage tariff costs effectively, as evidenced by its solid earnings guidance. However, the score is capped by a high valuation (36x P/E) and balance sheet leverage risks. Investors are paying a premium for quality and stability in a slow-growth environment.
Positive Factors
Strong Industrial Growth
The strong growth in the Industrial segment indicates robust demand and effective market penetration, which can drive sustained revenue and profitability.
Cash Flow Management
Effective cash flow management ensures liquidity and financial flexibility, enabling the company to invest in growth opportunities and manage debt.
Successful Acquisitions
Strategic acquisitions enhance product offerings and market reach, contributing to long-term growth and competitive positioning.
Negative Factors
High Financial Leverage
High leverage and negative equity can pose financial risks, limiting the company's ability to withstand economic downturns or invest in growth.
Decreased Operating Margin
Decreased margins due to tariffs can impact profitability, reducing the company's ability to reinvest in business operations and innovation.
Market Uncertainty
Ongoing market uncertainty can hinder strategic planning and growth, affecting long-term business stability and performance.

Mettler-Toledo (MTD) vs. SPDR S&P 500 ETF (SPY)

Mettler-Toledo Business Overview & Revenue Model

Company DescriptionMettler-Toledo International Inc. engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection, x-ray, checkweighing, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company's retail weighing solutions consist of networked scales and software, stand-alone scales, and automated packaging and labeling solutions for handling fresh goods. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. The company was incorporated in 1991 and is based in Columbus, Ohio.
How the Company Makes MoneyMettler-Toledo generates revenue through multiple key streams including the sale of its precision instruments, which encompass scales, balances, and analytical equipment. The company also derives income from its service offerings, which include maintenance, calibration, and support services that ensure the optimal performance of their equipment. Additionally, Mettler-Toledo benefits from recurring revenue through consumables and software solutions integrated with their measurement instruments. Strategic partnerships with industry leaders and compliance with regulatory standards enhance their market reach and customer retention, contributing significantly to their earnings.

Mettler-Toledo Key Performance Indicators (KPIs)

Any
Any
Revenue By Segment
Revenue By Segment
Analyzes income from different business segments, highlighting which areas drive growth and profitability, and where the company might be vulnerable or have expansion opportunities.
Chart InsightsMettler-Toledo's Retail segment experienced a notable surge in 2023, peaking in Q3, but faced a decline by year-end. The Laboratory segment shows steady growth, with a significant uptick expected by the end of 2024, suggesting strong demand resilience. The Industrial segment remains relatively stable, with minor fluctuations, indicating consistent performance. The absence of earnings call insights leaves the reasons for these trends open to market dynamics and internal strategic shifts.
Data provided by:The Fly

Mettler-Toledo Earnings Call Summary

Earnings Call Date:Nov 06, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 05, 2026
Earnings Call Sentiment Neutral
The earnings call presented a mixed picture with solid sales and EPS growth, driven by strong performance in the Industrial segment and successful acquisitions. However, challenges such as decreased operating margins due to tariff costs, and uncertainty in China and Europe, were notable lowlights. Despite these challenges, the guidance for 2026 remains cautiously optimistic.
Q3-2025 Updates
Positive Updates
Solid Overall Sales Performance
Sales in the quarter were $1.03 billion, representing a local currency increase of 6% and 5% excluding acquisitions. On a U.S. dollar reported basis, sales increased 8%.
Strong Industrial Growth
Industrial sales increased 9%, with core Industrial growing 10% and Product Inspection growing 7%. This segment showed strong performance, particularly in the Americas.
Adjusted EPS Growth
Adjusted EPS for the quarter was $11.15, a 9% increase over the prior year, despite facing gross headwinds from tariffs.
Successful Acquisitions
Several smaller acquisitions were completed, adding to North American distribution and life science equipment offerings, with the acquisitions expected to contribute approximately 1% to sales.
Positive Outlook for 2026
Initial guidance for 2026 projects local currency sales to increase approximately 4% and adjusted EPS to grow 8% to 9%, with foreign exchange estimated to be a slight headwind.
Negative Updates
Decreased Operating Margin
Adjusted operating margin decreased by 100 basis points, or down 30 basis points on a currency-neutral basis, primarily due to incremental tariff costs.
Tariff Challenges
Tariffs reduced operating margin by 140 basis points, with a significant gross headwind to EPS of 6% for the quarter and 5% for the full year.
Softness in China and Europe
Local currency sales in China increased only 2%, and Europe is projected to have low single-digit growth next year amid challenging market conditions.
Market Uncertainty
Continued uncertainty related to trade disputes, governmental policies, and geopolitical tensions, with no significant improvement assumed in market conditions for the coming year.
Company Guidance
During the Mettler-Toledo Third Quarter 2025 Earnings Conference Call, the company provided detailed guidance for the fourth quarter and full year 2025, as well as initial thoughts for 2026. For Q4 2025, the company expects local currency sales growth of approximately 3%, with operating margins decreasing by about 200 basis points due to higher tariff costs. Adjusted EPS for the quarter is projected to range from $12.68 to $12.88, reflecting a growth rate of 2% to 4%. For the full year 2025, local currency sales growth is forecasted at approximately 2%, or 3.5% excluding shipping delays, with adjusted EPS expected to be between $42.05 and $42.25. Looking ahead to 2026, Mettler-Toledo anticipates local currency sales growth of around 4%, with adjusted EPS projected to grow by 8% to 9%, ranging from $45.35 to $46. The guidance incorporates factors such as U.S. import tariffs, geopolitical tensions, and ongoing investments in automation and digitalization.

Mettler-Toledo Financial Statement Overview

Summary
Strong profitability and solid cash generation support the score, but the balance sheet is a major risk due to significant leverage and negative equity, which raises financial resilience concerns.
Income Statement
Mettler-Toledo demonstrates strong profitability with consistent gross and net profit margins. The TTM (Trailing-Twelve-Months) shows a slight revenue growth of 1.94%, indicating stability in revenue generation. However, the revenue growth rate has been inconsistent over the years, with some periods of decline. The EBIT and EBITDA margins remain robust, reflecting efficient operational management.
Balance Sheet
The balance sheet reveals significant financial leverage, with a negative stockholders' equity leading to a high and negative debt-to-equity ratio. This indicates potential financial risk. Return on equity is negative due to the negative equity, which is concerning. The equity ratio is also negative, highlighting a reliance on debt financing.
Cash Flow
Cash flow analysis shows a positive trend in free cash flow growth, particularly in the TTM period. The operating cash flow to net income ratio is healthy, indicating good cash generation relative to net income. The free cash flow to net income ratio is also strong, suggesting effective cash management. However, the company's high leverage could impact future cash flow stability.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.94B3.87B3.79B3.92B3.72B3.09B
Gross Profit2.30B2.25B2.17B2.24B2.11B1.74B
EBITDA1.23B1.22B1.18B1.24B1.10B885.96M
Net Income835.73M863.14M788.78M872.50M768.99M602.74M
Balance Sheet
Total Assets3.52B3.24B3.36B3.49B3.33B2.81B
Cash, Cash Equivalents and Short-Term Investments69.06M59.36M69.81M95.97M98.56M94.25M
Total Debt2.21B2.13B2.20B2.13B1.80B1.33B
Total Liabilities3.77B3.37B3.51B3.47B3.16B2.53B
Stockholders Equity-249.20M-126.89M-149.94M24.79M171.42M282.68M
Cash Flow
Free Cash Flow889.48M864.45M860.55M737.83M801.25M632.21M
Operating Cash Flow996.37M968.35M965.87M859.07M908.83M724.70M
Investing Cash Flow-204.52M-119.46M-131.69M-139.40M-314.11M-100.36M
Financing Cash Flow-786.73M-855.98M-859.59M-716.04M-590.55M-743.91M

Mettler-Toledo Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1373.24
Price Trends
50DMA
1430.30
Negative
100DMA
1383.01
Negative
200DMA
1285.60
Positive
Market Momentum
MACD
-9.19
Positive
RSI
38.17
Neutral
STOCH
14.56
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MTD, the sentiment is Negative. The current price of 1373.24 is below the 20-day moving average (MA) of 1444.67, below the 50-day MA of 1430.30, and above the 200-day MA of 1285.60, indicating a neutral trend. The MACD of -9.19 indicates Positive momentum. The RSI at 38.17 is Neutral, neither overbought nor oversold. The STOCH value of 14.56 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MTD.

Mettler-Toledo Risk Analysis

Mettler-Toledo disclosed 31 risk factors in its most recent earnings report. Mettler-Toledo reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Mettler-Toledo Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$37.86B29.2820.62%0.72%6.73%3.34%
73
Outperform
$22.08B34.0932.99%6.90%3.86%
71
Outperform
$28.05B34.254.77%7.93%
69
Neutral
$20.81B21.9513.69%1.80%13.74%14.87%
67
Neutral
$154.61B43.347.05%0.53%2.90%-4.81%
66
Neutral
$217.39B32.6213.04%0.30%3.91%7.09%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MTD
Mettler-Toledo
1,373.24
30.81
2.30%
A
Agilent
133.85
-13.59
-9.22%
DHR
Danaher
218.89
5.97
2.80%
DGX
Quest Diagnostics
187.03
27.52
17.26%
TMO
Thermo Fisher
578.61
-13.05
-2.21%
WAT
Waters
370.72
-40.47
-9.84%

Mettler-Toledo Corporate Events

Executive/Board Changes
Mettler-Toledo Adds Experienced Independent Director to Board
Positive
Jan 20, 2026

On January 16, 2026, Mettler-Toledo’s board appointed Michael J. Tokich as an independent director, effective February 5, 2026, expanding the board from nine to ten members with compensation aligned to the company’s other independent directors and no related-party arrangements disclosed. Announced publicly on January 20, 2026, the appointment brings to Mettler-Toledo nearly two decades of U.S. public company CFO experience from Tokich’s long tenure at healthcare and life sciences firm STERIS, bolstering the company’s financial, operational and IT expertise at board level and potentially strengthening its governance and strategic oversight for stakeholders.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 21, 2026